Journal: Eclinical medicine

Filtra

Data

Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in na‹ve patients with spinal muscular atrophy and following switch from other therapies

Torna in alto